By GATC Health Corp.
Publication Date: 2025-12-04 21:01:00
BOSTON, Dec. 4, 2025 (GLOBE NEWSWIRE) — GATC Health Corp, a leading tech bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announced that it will host a virtual key opinion leader (KOL) event on Wednesday, December 10, 2025 at 1:00 p.m. ET/10:00 a.m. PT. The event will feature Lin Yu, PhD (former Managing Director, Oppenheimer Healthcare Investment Banking), Tomas Philipson, PhD (former Acting Chairman, Council of Economic Advisers, Executive Office of the President) and Greg Sarafin (former Global Vice Chair, Ernst & Young), who will join senior management team members Rahul Gupta, MD, MPH, MBA, FACP (former Director, National Drug Control Policy; President, GATC Health) and Tyrone Lam (Chief Business). Officer, GATC Health) to discuss the company’s Derisq™AI report, which provides predictive, detailed risk assessment for drug candidates. To register, click here.
The Derisq AI Report uses GATC Health…
